Call 08047308287 71% Response Rate

Send Email

Migrane attack medicine

Our range of products include suviray 70mg/ml ( erenumab ) injection in pre-filled syringe.
Suviray 70mg/ml ( Erenumab ) Injection in pre-filled syringe
  • Suviray 70mg/ml ( Erenumab ) Injection in pre-filled syringe
  • Suviray 70mg/ml ( Erenumab ) Injection in pre-filled syringe
  • Suviray 70mg/ml ( Erenumab ) Injection in pre-filled syringe

Suviray 70mg/ml ( Erenumab ) Injection in pre-filled syringe

Get Latest Price

Product Brochure

Product Details:
BrandNovartis
Usage/ApplicationClinical
CompositionErenumab Injection
DoseInjection in pre-filled syringe
Medicine TypeInjection
Product TypeFinished Product
Form Of MedicineInjection in prefilled syringe
Packaging Type1 vial

SUVIRAY :Erenumab - (Aimovig) is a new medication used for preventing migraine attacks. It received the Food and Drug Administration's (FDA) approval on May 17, 2018. It belongs to a new class of drugs called calcitonin gene-related peptide receptor (CGRP-R) antagonist. CGRP-R is a chemical produced by the body that acts on blood vessels in the brain which are believed to be responsible for the development of migraines. Erenumab reduces the number of monthly migraine attacks by blocking CGRP-R receptors on blood vessels.

Get Best QuoteRequest A Callback

EXPLORE MORE CATEGORIES

Contact Us
 
Thank youYour Enquiry has been sent successfully.
© Speciality Healthcare Solutions. All Rights Reserved (Terms of Use)Developed and managed by IndiaMART InterMESH Ltd.